Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease.
about
Machado-Joseph Disease: from first descriptions to new perspectives.Cell biology of spinocerebellar ataxiaMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Allele-specific silencing of mutant huntingtin in rodent brain and human stem cellsSilencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic miceCurrent prospects for RNA interference-based therapiesDose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neuronsOverexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph diseaseDesign of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype.Huntington's disease: silencing a brutal killer.Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse ModelsOligonucleotide-based strategies to combat polyglutamine diseases.Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi.RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph diseaseAn evaluation of oligonucleotide-based therapeutic strategies for polyQ diseasesRNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts.Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23RNAi medicine for the brain: progresses and challenges.Consensus paper: management of degenerative cerebellar disorders.Splice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6.Toward understanding Machado-Joseph diseaseAllele-selective inhibition of trinucleotide repeat genes.Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 modelsRecent advances in RNA interference therapeutics for CNS diseases.Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteinsShort non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.Toward RNAi therapy for the polyglutamine disease Machado-Joseph diseasess-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.Disease-causing allele-specific silencing by RNA interference.Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.Silencing of CDK5 as potential therapy for Alzheimer's disease.RNA therapy for polyglutamine neurodegenerative diseases.Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.Research progress in allele-specific expression and its regulatory mechanisms.Lentiviral vector-mediated RNA silencing in the central nervous system.Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
P2860
Q21202868-7AC1FD3D-8D4A-41F1-B53C-96DF56231AB4Q26829511-E8F38CC7-CBAF-4E12-895D-83696F6B4627Q27005950-1C0ECA7B-2F65-4D24-BE35-CE4AB254F3B1Q27324212-21F3E23A-E948-4620-A47B-5BE7A2554092Q27324749-7393295C-0109-4F0F-BA63-537F0BC916A2Q28235733-7F898277-1A5A-470F-AAC1-1194AE41C1EBQ28566948-2605E35C-1D05-41D3-BDD9-47CCD9682F45Q28568604-DEAF7CF9-AF22-49E2-A2D1-22E87646068BQ33507519-D6FE2371-D6B4-4F12-B599-989B9C5CEC55Q33586461-63AC9587-B439-4F1B-AC01-577BD95621FFQ33635375-63A96C27-B926-431E-BBEF-65A507C84BFEQ33791247-C3E7E995-1B0C-4034-B9FF-10713F23FF10Q33945342-AEEDD9ED-4E15-4BA5-8B37-E082355AC62CQ34075342-F5B650A9-82F8-42C0-A863-1AFBCA364BBEQ34187525-18E2ECC4-4CA0-4EB7-987B-FD060DA1CF82Q34235172-88875ED5-FA9B-43B5-AFA0-4A65147F2D87Q34499502-801E6972-5187-4E5F-8A1A-D03ADEF886CEQ34508264-051FB1E1-E59E-403B-BF60-14544946E46FQ34541372-BF31A635-C541-45D6-B681-93F5E600A37AQ34982838-F738E5C0-1931-44DB-ABE5-CB7EF3837C86Q35129909-BBF826CB-FAAF-43E0-A8FE-BB575386C436Q35203559-6B20DE7B-0A9E-44B1-BAC7-BAFDD2A1252AQ35837355-454E9010-75B6-4D1D-AE19-BE3D96B465FAQ36310758-EB304DA5-7BA9-4572-BC65-4023B156DEFAQ36583286-18C059CC-046B-4A52-9F80-CFE84D2B1493Q36983193-C188B478-F401-4EB4-BFB5-E182BEA12B75Q37027391-034801A0-9A4F-4478-B01D-2A1E09364F50Q37133999-91AD7475-363E-40B0-929D-4CCA6A8B8A5BQ37134134-790D2B6B-A2DC-4EBF-91F2-EEB9769041BBQ37254846-8E93889C-A5E2-47AC-B0A5-D7CDE19D02EAQ37271206-F50DF573-9202-4F23-A0DC-7A01C9CFB358Q37277394-76D1A243-1208-477C-81CE-B5A614FE6266Q37395054-FE71DA54-3FC7-401E-9E3E-33BBF5B275A6Q37536687-99FB9074-9113-4090-92CC-849D9C0DAC46Q37863144-98135462-47E5-416C-8290-C812FFF46F61Q37980319-BDEDB72A-8EAA-4650-AB22-0650970A5D3AQ38045212-9C95E0BC-EC98-4F34-B9CE-8D0728FD7DDEQ38100946-ECA57723-7589-4038-B2E5-F88D343707CDQ38148784-C514C12C-8E47-474D-B8E6-E7AAD13BF49CQ38167681-A3801CD7-F85F-4827-AF8B-8C218AD781FC
P2860
Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@ast
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@en
type
label
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@ast
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@en
prefLabel
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@ast
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@en
P2093
P2860
P50
P1433
P1476
Allele-specific RNA silencing ...... del of Machado-Joseph disease.
@en
P2093
Gwennaëlle Auregan
Isabel Nascimento-Ferreira
Noëlle Dufour
Philippe Hantraye
Raymonde Hassig
Sandro Alves
P2860
P356
10.1371/JOURNAL.PONE.0003341
P407
P577
2008-10-08T00:00:00Z